Unreliability of Serum- or Plasma-based Assays of D-dimer or Fibrin (Fibrinogen) Degradation Product for Diagnosing Periprosthetic Joint Infection: A Prospective Parallel Study

Abstract

Objective:: The ability of D-dimer to diagnose periprosthetic joint infection (PJI) before revision hip or knee arthroplasty is still controversial, and the differences in diagnostic ability between serum- or plasma-based assays of D-dimer and fibrin (fibrinogen) degradation product (FDP) are uncertain. The prospective parallel study was performed to determine the ability of D-dimer to diagnose PJI before revision hip or knee arthroplasty, and the differences in diagnostic ability between serum- or plasma-based assays of D-dimer and FDP.

Methods:: Patients undergoing knee or hip arthroplasty at our institution were prospectively enrolled into the following groups: those without inflammatory diseases who were undergoing primary arthroplasty (“Prim” group), those with inflammatory arthritis who were undergoing primary arthroplasty (“Prim/Inflam”), those undergoing revision arthroplasty because of aseptic failure (“Rev/Asept”), or those undergoing revision arthroplasty because of PJI (“Rev/PJI”). The ability of preoperative levels of D-dimer or FDP in serum or plasma to diagnose PJI in each group was assessed using areas under receiver operating characteristic curves (AUCs) and other diagnostic performance indicators. The diagnostic performance of these assays was compared with that of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR).

Results:: In the final analysis, Prim included 42 patients; Prim/Inflam, 40; Rev./Asept, 62; and Rev./PJI, 47. D-dimer assays led to AUCs of 0.635 in serum and 0.573 in plasma, compared to 0.593 and 0.607 for FDP. Even in combination with CRP or ESR, these assays failed to perform as well as the combination of CRP and ESR for diagnosing PJI.

Conclusion:: Levels of D-dimer or FDP in serum or plasma, whether used alone or together with CRP or ESR, are unreliable for diagnosing PJI before revision arthroplasty.

Keywords

D-Dimer / Diagnosis / Fibrin (fibrinogen) degradation product / Periprosthetic joint infection / Plasma / Serum

References

[1] Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg. American Volume. 2007;89(4):780–785.

[2] Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA. Current epidemiology of revision Total knee arthroplasty in the United States. J Arthroplasty. 2017;32(9):2663–2668.

[3] Fehring TK, Odum SM, Berend KR, Jiranek WA, Parvizi J, Bozic KJ, et al. Failure of irrigation and débridement for early postoperative periprosthetic infection. Clin Orthop Relat Res. 2013;471(1):250–257.

[4] Li R, Song L, Quan Q, et al. Detecting Periprosthetic joint infection by using mass spectrometry. J Bone Joint Surg. American Volume. 2021;103(20):1917–1926.

[5] Parvizi J, Gehrke T. International consensus group on Periprosthetic joint I. Definition of periprosthetic joint infection. J Arthroplasty. 2014;29(7):1331.

[6] Kanafani ZA, Sexton DJ, Pien BC, Varkey J, Basmania C, Kaye KS. Postoperative joint infections due to Propionibacterium species: a case-control study. Clin Infect Dis. 2009;49(7):1083–1085.

[7] Xu H, Xie J, Huang Q, Lei Y, Zhang S, Pei F. Plasma fibrin degradation product and D-dimer are of limited value for diagnosing Periprosthetic joint infection. J Arthroplasty. 2019;34(10):2454–2460.

[8] Shahi A, Kheir MM, Tarabichi M, Hosseinzadeh HRS, Tan TL, Parvizi J. Serum D-dimer test is promising for the diagnosis of Periprosthetic joint infection and timing of Reimplantation. J Bone Joint Surg. American Volume. 2017;99(17):1419–1427.

[9] Huang J, Zhang Y, Wang Z, Dong Y, Zhao Y, Zheng J, et al. The serum level of D-dimer is not suitable for distinguishing between prosthetic joint infection and aseptic loosening. J Orthop Surg Res. 2019;14(1):407.

[10] Pannu TS, Villa JM, Patel PD, Riesgo AM, Barsoum WK, Higuera CA. The utility of serum d-dimer for the diagnosis of Periprosthetic joint infection in revision Total hip and knee arthroplasty. J Arthroplasty. 2020;35(6):1692–1695.

[11] Qin L, Li F, Gong X, Wang J, Huang W, Hu N. Combined measurement of D-dimer and C-reactive protein levels: highly accurate for diagnosing chronic Periprosthetic joint infection. J Arthroplasty. 2020;35(1):229–234.

[12] Wixted CM, Charalambous LT, Kim BI, Case A, Hendershot EF, Seidelman JL, et al. D-dimer, erythrocyte sedimentation rate, and C-reactive protein sensitivities for Periprosthetic joint infection diagnosis. J Arthroplasty. 2023;38(5):914–917.

[13] Li R, Shao HY, Hao LB, Yu BZ, Qu PF, Zhou YX, et al. Plasma fibrinogen exhibits better performance than plasma D-dimer in the diagnosis of Periprosthetic joint infection: a multicenter retrospective study. J Bone Joint Surg. American Volume. 2019;101(7):613–619.

[14] Pannu TS, Villa JM, Jimenez DA, Riesgo AM, Higuera CA. Does performance of D-dimer for diagnosis of Periprosthetic joint infection change with the virulence of infecting organism? J Arthroplasty. 2023;38(7 Suppl 2):S389–S393.

[15] Tarabichi S, Goh GS, Baker CM, Chisari E, Shahi A, Parvizi J. Plasma D-dimer is noninferior to serum C-reactive protein in the diagnosis of Periprosthetic joint infection. J Bone Joint Surg. American Volume. 2023;105(7):501–508.

[16] Pannu TS, Villa JM, Riesgo AM, Higuera CA. Letter to the editor on "combined measurement of D-dimer and C-reactive protein levels: highly accurate for diagnosing chronic Periprosthetic joint infection". J Arthroplasty. 2021;36(2):e5.

[17] Xu H, Xie JW, Yang JL, Huang ZY, Pei FX. Role of D-dimer and fibrinogen in the diagnosis of Periprosthetic joint infection: a systematic review and meta-analysis. Orthop Surg. 2021;13(3):692–700.

[18] Wang Y, Man Z, Yuan T, Cao H, Sun S. Reliability of d-dimer determination in diagnosis of Peri-prosthetic joint infection: a systematic review and meta-analysis. Surg Infect (Larchmt). 2021;22(4):374–382.

[19] Li C, Margaryan D, Ojeda-Thies C, Perka C, Trampuz A. Meta-analysis of serum and/or plasma D-dimer in the diagnosis of periprosthetic joint infection. J Orthop Surg Res. 2020;15(1):298.

[20] Fujimoto T, Kaneko T, Sunakawa T, Ikegami H, Musha Y. Elevation of fibrin degradation product (FDP) values prevents the negative conversion of serum CRP values after total knee arthroplasty. J Orthop. 2018;15(4):940–944.

[21] Xu H, Xie J, Zhou J, Wang X, Wang D, Huang Z, et al. Ability of plasma-based or serum-based assays of D-dimer and FDP for diagnosing periprosthetic joint infection: protocol for a prospective single-Centre, parallel comparative study. BMJ Open. 2021;11(7):e046442.

[22] Sharma A, Sikka M, Gomber S, Sharma S. Plasma fibrinogen and D-dimer in children with sepsis: a single-center experience. Iran J Pathol. 2018;13(2):272–275.

[23] Lee YS, Lee YK, Han SB, Nam CH, Parvizi J, Koo KH. Natural progress of D-dimer following total joint arthroplasty: a baseline for the diagnosis of the early postoperative infection. J Orthop Surg Res. 2018;13(1):36.

[24] Yokomichi ALY, Rodrigues VDC, Moroz A, et al. Detection of factor VIII and D-dimer biomarkers for venous thromboembolism diagnosis using electrochemistry immunosensor. Talanta. 2020;219:121241.

[25] Ribera T, Monreal L, Armengou L, Ríos J, Prades M. Synovial fluid D-dimer concentration in foals with septic joint disease. J Vet Intern Med. 2011;25(5):1113–1117.

[26] Gando S. Role of fibrinolysis in sepsis. Semin Thromb Hemost. 2013;39(4):392–399.

[27] Rodelo JR, De La Rosa G, Valencia ML, et al. D-dimer is a significant prognostic factor in patients with suspected infection and sepsis. Am J Emerg Med. 2012;30(9):1991–1999.

[28] Shi D, Xia T, Feng H, Cheng Q. Evaluating the diagnostic value of vWF:Ag, D-D and FDP in patients with acute cerebral infarction using ROC curves. Exp Ther Med. 2014;7(6):1573–1577.

[29] Balato G, De Franco C, Balboni F, et al. The role of D-dimer in periprosthetic joint infection: a systematic review and meta-analysis. Diagnosis (Berlin, Germany). 2021;9(1):3–10.

[30] Pannu TS, Villa JM, Manrique J, Higuera CA, Riesgo AM. Paradoxical behavior of plasma d-dimer from Explantation to Reimplantation in a two-stage revision for Periprosthetic joint infection. J Arthroplasty. 2022;37(8s):S977–S982.

[31] Shohat N, Goswami K, Fillingham Y, Tan TL, Calkins T, Della Valle CJ, et al. Diagnosing Periprosthetic joint infection in inflammatory arthritis: assumption is the enemy of true understanding. J Arthroplasty. 2018;33(11):3561–3566.

[32] Mirza SZ, Richardson SS, Kahlenberg CA, Blevins JL, Lautenbach C, Demetres M, et al. Diagnosing prosthetic joint infections in patients with inflammatory arthritis: a systematic literature review. J Arthroplasty. 2019;34(5):1032–1036.e2.

[33] Ali F, Wilkinson JM, Cooper JR, Kerry RM, Hamer AJ, Norman P, et al. Accuracy of joint aspiration for the preoperative diagnosis of infection in total hip arthroplasty. J Arthroplasty. 2006;21(2):221–226.

[34] Saleh A, George J, Faour M, Klika AK, Higuera CA. Serum biomarkers in periprosthetic joint infections. Bone Joint Res. 2018;7(1):85–93.

[35] Sigmund IK, Holinka J, Staats K, Sevelda F, Lass R, Kubista B, et al. Inferior performance of established and novel serum inflammatory markers in diagnosing periprosthetic joint infections. Int Orthop. 2020;45(4):837–846.

RIGHTS & PERMISSIONS

2023 2023 The Authors. Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.